Ascendis Pharma A/S 2020 SR
The report outlines Ascendis Pharma's sustainability progress for 2020, focusing on four pillars: Patients, People, Planet, and Integrity. Key highlights include the submission of the company's first regulatory filings for a pediatric growth hormone deficiency therapy and the establishment of a Compliance Committee. The company aligned its strategy with four UN Sustainable Development Goals and implemented new policies for human rights and animal welfare. Additionally, Ascendis Pharma achieved gender balance on its Board of Directors and across management levels while expanding its global workforce to 482 employees.
Company: Ascendis Pharma A/S
Sector: Manufacturing
Country: Denmark
Year: 2020
Type: SR
Pages: 11
Back to company
Ascendis Pharma A/S
Corporate Responsibility Report
The report outlines Ascendis Pharma's sustainability progress for 2020, focusing on four pillars: Patients, People, Planet, and Integrity. Key highlights include the submission of the company's first regulatory filings for a pediatric growth hormone deficiency therapy and the establishment of a Compliance Committee. The company aligned its strategy with four UN Sustainable Development Goals and implemented new policies for human rights and animal welfare. Additionally, Ascendis Pharma achieved gender balance on its Board of Directors and across management levels while expanding its global workforce to 482 employees.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
Feb 1, 2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees